• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EHG
Click for more information
0.00% 0.0¢

EHG CORPORATION LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
EHG
Ann: Appendix 3B 		25/05/15 0 373
25/05/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  373 
EHG
Ann: Initial Director's Interest Notice for Ms Khoo 		19/05/15 0 329
19/05/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  329 
EHG
Ann: Initial Director's Interest Notice for Ms Ng 		19/05/15 0 356
19/05/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  356 
EHG
Ann: Initial Director's Interest Notice for Mr Koh 		19/05/15 0 216
19/05/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  216 
EHG
Ann: Final Director's Interest Notice for Mr Urquhart 		19/05/15 0 311
19/05/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  311 
EHG
Ann: Final Director's Interest Notice for Mr Sutton 		19/05/15 0 178
19/05/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  178 
EHG
Ann: Final Director's Interest Notice for Dr Schurmann 		19/05/15 0 208
19/05/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  208 
EHG
Ann: Results of General Meeting 		18/05/15 0 282
18/05/15 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  282 

See All Discussions arrow Created with Sketch.

Top Stories

Scientific conference spotlights PYC's work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.